tiprankstipranks
Abivax Announces Share Capital and Voting Rights
Company Announcements

Abivax Announces Share Capital and Voting Rights

Abivax SA (FR:ABVX) has released an update.

Pick the best stocks and maximize your portfolio:

Abivax, a clinical-stage biotech company, has disclosed its share capital and voting rights as of May 31, 2024, revealing a total of 62,930,818 shares and 69,950,376 theoretical voting rights. The company, known for developing treatments for chronic inflammatory diseases, reported 69,938,945 exercisable voting rights, excluding shares without voting rights.

For further insights into FR:ABVX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAbivax initiated with an Outperform at JMP Securities
TipRanks European Auto-Generated NewsdeskAbivax SA Ends Liquidity Contract, Reports Cash Balance
TheFlyAbivax data support potential of obefazimod as UC treatment option
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App